CO4560554A1 - Ligandos espirociclicos de un subtipo de receptor de la do- pamina - Google Patents
Ligandos espirociclicos de un subtipo de receptor de la do- paminaInfo
- Publication number
- CO4560554A1 CO4560554A1 CO97048585A CO97048585A CO4560554A1 CO 4560554 A1 CO4560554 A1 CO 4560554A1 CO 97048585 A CO97048585 A CO 97048585A CO 97048585 A CO97048585 A CO 97048585A CO 4560554 A1 CO4560554 A1 CO 4560554A1
- Authority
- CO
- Colombia
- Prior art keywords
- spyrocyclic
- pamina
- leagues
- receptor subtype
- sulfur
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
1. UN COMPUESTO DE FORMULA I. VER FORMULA I EN LA QUE a ESOXIGENO, CH2, C(CH3)2,NR^10, AZUFRE SO O S02; b ES OXIGENO, CH2,C=O, C=NR^11, C+NOH, SO2, AZUFRE SO,C=NO-ALQUILO C1-C5 O CR^7R^8; CADA UNO DE LOS R^1 A LOS R^8 SE SELECCIONAN, INDEPENDIENTEMENTE, ENTRE HIDROGENO, HALO (POR EJEMPLO, CLORO, FLUORO, BROMO O YODO), TRIFUORME- TILO, CIANO, HIDROXI, R^7 Y R^8 O JUNTOS PUEDEN SER C(=O)NH2 O C(=O)N- ALQUILO C1-C4, CON LA CONDICION DE QUE nI R^7 NI R^8 PUEDEN SER HALO CUANDO A ES OXIGENO, NR^11, AZUFRE,SO,O SO2; Y CADA UNO DE R^10 Y R^11 SE SELECCIONAN INDEPEN- DIENTE, ENTRE HIDROGENO, BENCILO Y ALQUILO C1-C6; Y LAS SALES FARMACEUTICAMENTE ACPETABLES DE DICHOS COMPUESTOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2479796P | 1996-08-26 | 1996-08-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4560554A1 true CO4560554A1 (es) | 1998-02-10 |
Family
ID=21822443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO97048585A CO4560554A1 (es) | 1996-08-26 | 1997-08-22 | Ligandos espirociclicos de un subtipo de receptor de la do- pamina |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6664258B1 (es) |
| EP (1) | EP0925291B1 (es) |
| JP (1) | JP3152941B2 (es) |
| AP (1) | AP9701075A0 (es) |
| AR (1) | AR013836A1 (es) |
| AT (1) | ATE311377T1 (es) |
| AU (1) | AU3632297A (es) |
| CA (1) | CA2264549C (es) |
| CO (1) | CO4560554A1 (es) |
| DE (1) | DE69734774D1 (es) |
| GT (1) | GT199700096A (es) |
| HN (1) | HN1997000117A (es) |
| HR (1) | HRP970455A2 (es) |
| ID (1) | ID18076A (es) |
| IL (1) | IL128050A0 (es) |
| IS (1) | IS4969A (es) |
| MA (1) | MA26437A1 (es) |
| PA (1) | PA8436501A1 (es) |
| PE (1) | PE108498A1 (es) |
| TN (1) | TNSN97143A1 (es) |
| WO (1) | WO1998008835A1 (es) |
| ZA (1) | ZA977597B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0953567A3 (en) | 1998-04-29 | 2003-04-02 | Pfizer Products Inc. | Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity |
| AU754529B2 (en) * | 1998-09-22 | 2002-11-21 | Yamanouchi Pharmaceutical Co., Ltd. | Cyanophenyl derivatives |
| EP1177792A3 (en) * | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
| GB0328906D0 (en) | 2003-12-12 | 2004-01-14 | Syngenta Participations Ag | Chemical compounds |
| CN106831541B (zh) | 2011-11-18 | 2019-09-06 | 赫普泰雅治疗有限公司 | 毒蕈碱性m1受体激动剂 |
| GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| GB201617454D0 (en) * | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE758919A (fr) | 1969-11-15 | 1971-05-13 | Merck Patent Gmbh | Spiro-composes |
| US3932425A (en) | 1974-04-12 | 1976-01-13 | The Upjohn Company | Benzospiran derivatives |
| US4010201A (en) | 1974-04-12 | 1977-03-01 | The Upjohn Company | Organic compounds |
| US4025558A (en) | 1974-04-12 | 1977-05-24 | The Upjohn Company | Organic compounds |
| DE2818329A1 (de) | 1978-04-26 | 1979-11-08 | Yoshitomi Pharmaceutical | Spiro eckige klammer auf cyclohexan- 1,9'-thioxanthen eckige klammer zu -verbindungen |
| CA2091204C (en) | 1992-03-11 | 1997-04-08 | Ronald J. Mattson | Antiischemic-piperazinyl and piperidinyl-cyclohexanes |
| ES2133416T3 (es) | 1992-10-23 | 1999-09-16 | Merck Sharp & Dohme | Ligandos de subtipos de receptores de dopamina. |
| GB9317631D0 (en) | 1993-08-25 | 1993-10-13 | Bxl Plastics Ltd | Multi-layered composite |
| US5403846A (en) | 1993-11-22 | 1995-04-04 | Merck & Co., Inc. | Spirocycles |
| AU691296B2 (en) | 1994-05-06 | 1998-05-14 | Pharmacopeia Drug Discovery, Inc. | Combinatorial dihydrobenzopyran library |
| GB9410031D0 (en) | 1994-05-19 | 1994-07-06 | Merck Sharp & Dohme | Therapeutic agents |
-
1997
- 1997-08-08 JP JP51143198A patent/JP3152941B2/ja not_active Expired - Fee Related
- 1997-08-08 WO PCT/IB1997/000978 patent/WO1998008835A1/en active IP Right Grant
- 1997-08-08 CA CA002264549A patent/CA2264549C/en not_active Expired - Fee Related
- 1997-08-08 DE DE69734774T patent/DE69734774D1/de not_active Expired - Lifetime
- 1997-08-08 AT AT97932964T patent/ATE311377T1/de not_active IP Right Cessation
- 1997-08-08 US US09/242,819 patent/US6664258B1/en not_active Expired - Fee Related
- 1997-08-08 AU AU36322/97A patent/AU3632297A/en not_active Abandoned
- 1997-08-08 EP EP97932964A patent/EP0925291B1/en not_active Expired - Lifetime
- 1997-08-08 IL IL12805097A patent/IL128050A0/xx unknown
- 1997-08-12 HN HN1997000117A patent/HN1997000117A/es unknown
- 1997-08-19 PE PE1997000731A patent/PE108498A1/es not_active Application Discontinuation
- 1997-08-21 AP APAP/P/1997/001075A patent/AP9701075A0/en unknown
- 1997-08-22 HR HR60/024,797A patent/HRP970455A2/hr not_active Application Discontinuation
- 1997-08-22 AR ARP970103835A patent/AR013836A1/es unknown
- 1997-08-22 CO CO97048585A patent/CO4560554A1/es unknown
- 1997-08-22 PA PA19978436501A patent/PA8436501A1/es unknown
- 1997-08-25 ID IDP972950A patent/ID18076A/id unknown
- 1997-08-25 TN TNTNSN97143A patent/TNSN97143A1/fr unknown
- 1997-08-25 MA MA24775A patent/MA26437A1/fr unknown
- 1997-08-25 ZA ZA977597A patent/ZA977597B/xx unknown
- 1997-08-25 GT GT199700096A patent/GT199700096A/es unknown
-
1999
- 1999-02-05 IS IS4969A patent/IS4969A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HN1997000117A (es) | 1997-12-26 |
| IL128050A0 (en) | 1999-11-30 |
| WO1998008835A1 (en) | 1998-03-05 |
| HRP970455A2 (en) | 1998-08-31 |
| JP2000502360A (ja) | 2000-02-29 |
| US6664258B1 (en) | 2003-12-16 |
| DE69734774D1 (de) | 2006-01-05 |
| PE108498A1 (es) | 1999-01-29 |
| PA8436501A1 (es) | 2000-05-24 |
| GT199700096A (es) | 1999-02-16 |
| AR013836A1 (es) | 2001-01-31 |
| AU3632297A (en) | 1998-03-19 |
| CA2264549C (en) | 2004-09-14 |
| IS4969A (is) | 1999-02-05 |
| EP0925291B1 (en) | 2005-11-30 |
| AP9701075A0 (en) | 1997-10-31 |
| ID18076A (id) | 1998-02-26 |
| MA26437A1 (fr) | 2004-12-20 |
| ZA977597B (en) | 1999-02-25 |
| ATE311377T1 (de) | 2005-12-15 |
| TNSN97143A1 (fr) | 2005-03-15 |
| EP0925291A1 (en) | 1999-06-30 |
| JP3152941B2 (ja) | 2001-04-03 |
| CA2264549A1 (en) | 1998-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4560554A1 (es) | Ligandos espirociclicos de un subtipo de receptor de la do- pamina | |
| ES2109218T3 (es) | Bis-(hidroximetil)ciclobutil-purinas y -pirimidinas. | |
| NO941080L (no) | Fluorinerte 17 ater | |
| DK364489A (da) | Boreindretning til fremstilling af borehuller med en underskaering | |
| ES2160127T3 (es) | Metodo antipsicotico con derivados de tiadiazol y oxadiazol. | |
| CO4970752A1 (es) | Nuevos derivados de isatin y composiciones farmaceuticas conteniendo tales isatines | |
| KR900701717A (ko) | 2--1,3-시클로헥산디온제초제 화합물과 이를 이용한 조성물 및 식물억제방법 | |
| IE850140L (en) | Methylenediphosphonic acid derivatives antirheumatic agents | |
| ES520860A0 (es) | Procedimiento de preparar teofilinas 7-substituidas. | |
| NO902866D0 (no) | Azetidiner, fremgangsmaate til deres fremstilling og deresanvendelse som mellomprodukter i fremstillingen av forbindelser med antimikrobiell virkning. | |
| ES2155660T3 (es) | Derivados de bencimidazol, de benzoxazol y de benzotiazol, utilizables como inhibidores de la interleuquina 1beta. | |
| EP0217747A3 (en) | Nematocidal agents | |
| AR037880A1 (es) | Derivados de benzodifuranimidazolina y benzofuranimidazolina y su uso para el tratamiento de glaucoma | |
| AR034400A1 (es) | Piranoindoles, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de glaucoma | |
| NO20003128L (no) | Nye p-aminofenylderivater og deres anvendelse | |
| DK231682A (da) | Soedemiddel | |
| ES2054933T3 (es) | Ciclopropanocarboxamidas, procedimiento para su obtencion y su empleo para la lucha contra las pestes. | |
| DK228086A (da) | Substituerede isoxazol-derivater med antiviral virkning og fremgangsmaade af saadanne derivater | |
| ES2186401T3 (es) | Composiciones fungicidas. | |
| CO4950541A1 (es) | Inhibidores de proteasas | |
| AU6962981A (en) | 4-hydroxy-1,2-benzoisothiazole-3(2h)-one-1,1-dioxides used as sweetening agents | |
| NO921558L (no) | Soetningsmidler som stammer fra l-glutaminsyre; fremgangsmaate for fremstilling av et soetningsmiddel | |
| DK469381A (da) | Piperidinderivater og fremgangsmaade til deres fremstilling | |
| WO2003031984A3 (de) | Verfahren zur sequenzanalyse von polypeptiden | |
| ES463709A2 (es) | Procedimiento para la preparacion de 1-metil-2-(fenil-oxi-metil)-5-nitro-imidazoles. |